157 related articles for article (PubMed ID: 24016843)
1. Soluble silica inhibits osteoclast formation and bone resorption in vitro.
Mladenović Ž; Johansson A; Willman B; Shahabi K; Björn E; Ransjö M
Acta Biomater; 2014 Jan; 10(1):406-18. PubMed ID: 24016843
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of osteoclast activities by SCPC bioceramic promotes osteoblast-mediated graft resorption and osteogenic differentiation.
El-Ghannam A; Nakamura M; Muguruza LB; Sarwar U; Hassan M; Fotawi RA; Horowitz R
J Biomed Mater Res A; 2021 Sep; 109(9):1714-1725. PubMed ID: 33733590
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of orthosilicic acid on osteoclastogenesis in RANKL-stimulated RAW264.7 cells.
Magnusson C; Uribe P; Jugdaohsingh R; Powell JJ; Johansson A; Ransjö M
J Biomed Mater Res A; 2021 Oct; 109(10):1967-1978. PubMed ID: 33817967
[TBL] [Abstract][Full Text] [Related]
4. The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration.
Mao L; Xia L; Chang J; Liu J; Jiang L; Wu C; Fang B
Acta Biomater; 2017 Oct; 61():217-232. PubMed ID: 28807800
[TBL] [Abstract][Full Text] [Related]
5. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
6. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
Idris AI; Landao-Bassonga E; Ralston SH
Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
[TBL] [Abstract][Full Text] [Related]
7. Luteolin inhibition of V-ATPase a3-d2 interaction decreases osteoclast resorptive activity.
Crasto GJ; Kartner N; Yao Y; Li K; Bullock L; Datti A; Manolson MF
J Cell Biochem; 2013 Apr; 114(4):929-41. PubMed ID: 23129004
[TBL] [Abstract][Full Text] [Related]
8. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
9. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
Schumacher M; Wagner AS; Kokesch-Himmelreich J; Bernhardt A; Rohnke M; Wenisch S; Gelinsky M
Acta Biomater; 2016 Jun; 37():184-94. PubMed ID: 27084107
[TBL] [Abstract][Full Text] [Related]
10. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
12. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
13. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
[TBL] [Abstract][Full Text] [Related]
14. Osteogenic effects of bioactive glass on bone marrow stromal cells.
Radin S; Reilly G; Bhargave G; Leboy PS; Ducheyne P
J Biomed Mater Res A; 2005 Apr; 73(1):21-9. PubMed ID: 15693019
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin inhibits osteoclastogenesis while enhancing osteoclast activity via nitric oxide and interleukin-1β-mediated signaling pathways.
Gramoun A; Azizi N; Sodek J; Heersche JN; Nakchbandi I; Manolson MF
J Cell Biochem; 2010 Nov; 111(4):1020-34. PubMed ID: 20672308
[TBL] [Abstract][Full Text] [Related]
16. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin F(2alpha) negatively regulates bone resorption in murine osteoclast development.
Kamon M; Fujita D; Goto N; Amano H; Sakamoto K
Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):26-33. PubMed ID: 18638564
[TBL] [Abstract][Full Text] [Related]
18. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
19. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation.
Smith R; Ransjö M; Tatarczuch L; Song SJ; Pagel C; Morrison JR; Pike RN; Mackie EJ
J Bone Miner Res; 2004 Mar; 19(3):507-16. PubMed ID: 15040840
[TBL] [Abstract][Full Text] [Related]
20. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]